Grégoire Wuerzner

Angiotensin II Suppression in Humans by the Orally Active Renin Inhibitor Aliskiren (SPP100)

Juerg Nussberger, Grégoire Wuerzner, C. Jensen et al. · Hypertension · 2002 · 407 citations

Pharmacy, Pharmacology, Pharmacotherapy +14

May Measurement Month 2017: an analysis of blood pressure screening results worldwide

Thomas Beaney, Aletta E. Schutte, Maciej Tomaszewski et al. · The Lancet Global Health · 2018 · 338 citations · Full text

Medicine, Preventive Medicine, Public Health Practice +17

May Measurement Month 2018: a pragmatic global screening campaign to raise awareness of blood pressure by the International Society of Hypertension

Thomas Beaney, Louise M. Burrell, Rafael R. Castillo et al. · European Heart Journal · 2019 · 268 citations · Full text

Medicine, Health Promotion, Preventive Medicine +17

Cuffless blood pressure measuring devices: review and statement by the European Society of Hypertension Working Group on Blood Pressure Monitoring and Cardiovascular Variability

George S. Stergiou, Ramakrishna Mukkamala, Alberto Avolio et al. · Journal of Hypertension · 2022 · 201 citations · Full text

Engineering, Cardiology, Bioinstrumentation +16

Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes by Sodium–Glucose Cotransporter 2 Inhibitor Treatment: The FIDELITY Analysis

Peter Rossing, Stefan D. Anker, Gerasimos Filippatos et al. · Diabetes Care · 2022 · 199 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +17